Published in AIDS Care on February 01, 2007
What do we know about older adults and HIV? A review of social and behavioral literature. AIDS Care (2011) 1.21
Body image disturbance and health behaviors among sexual minority men living with HIV. Health Psychol (2014) 0.93
Depression longitudinally mediates the association of appearance concerns to ART non-adherence in HIV-infected individuals with a history of injection drug use. J Behav Med (2012) 0.88
Assessing appearance-related disturbances in HIV-infected men who have sex with men (MSM): psychometrics of the body change and distress questionnaire-short form (ABCD-SF). AIDS Behav (2014) 0.82
Appearance concerns and psychological distress among HIV-infected individuals with injection drug use histories: prospective analyses. AIDS Patient Care STDS (2012) 0.80
The role of BMI change on smoking abstinence in a sample of HIV-infected smokers. AIDS Care (2015) 0.75
Cognitive Behavioral Therapy for Body Image and Self-Care (CBT-BISC) in Sexual Minority Men Living With HIV: A Randomized Controlled Trial. Health Psychol (2017) 0.75
The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry (1974) 16.18
Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol (2000) 7.77
Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis (2005) 2.55
Relationship between HAART adherence and adipose tissue alterations. J Acquir Immune Defic Syndr (2002) 1.97
Relationship of satisfaction with body size and trying to lose weight in a national survey of overweight and obese women aged 40 and older, United States. Prev Med (2002) 1.83
Sexual dysfunction with protease inhibitors. Lancet (1999) 1.73
Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy. AIDS (2001) 1.63
Body image dissatisfaction among males across the lifespan: a review of past literature. J Psychosom Res (2004) 1.60
Sexual orientation and prevalence of body dissatisfaction and eating disordered behaviors: a population-based study of adolescents. Int J Eat Disord (1996) 1.47
Pursuit of the muscular ideal: Physical and psychological consequences and putative risk factors. Clin Psychol Rev (2004) 1.44
Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment. AIDS (2001) 1.35
Endocrine disorders in men infected with human immunodeficiency virus. Am J Med (1988) 1.32
Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Read (2000) 1.20
A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals. Sex Transm Infect (2003) 1.17
Adverse effects of medications and trade-offs between length of life and quality of life in human immunodeficiency virus infection. Am J Med (2002) 1.16
What is body image? Behav Res Ther (1994) 1.10
Reasons for the adoption of celibacy among older men and women living with HIV/AIDS. J Sex Res (2003) 1.09
The relationship between lipodystrophy-associated body changes and measures of quality of life and mental health for HIV-positive adults. Qual Life Res (2005) 1.04
The influence of sexual orientation on body dissatisfaction in adult men and women. Int J Eat Disord (1996) 1.03
The effect of weight loss on body image in HIV-positive gay men. AIDS Care (2001) 0.95
Male sexual dysfunction associated with antiretroviral therapy. J Acquir Immune Defic Syndr (2002) 0.91
Diabetes in urban African Americans. Body image, satisfaction with size, and weight change attempts. Diabetes Educ (1997) 0.90
Ethnic differences in body image attitudes and perceptions among women infected with human immunodeficiency virus. J Am Diet Assoc (1999) 0.89
Body image dissatisfaction in homosexual and heterosexual males. J Nerv Ment Dis (1991) 0.86
Psychosexual problems in people with HIV infection: controlled study of gay men and men with haemophilia. AIDS Care (1994) 0.86
Protease inhibitors and erectile dysfunction. AIDS (2001) 0.85
Exercise status and sexual orientation as moderators of body image disturbance and eating disorders in males. Int J Eat Disord (2002) 0.82
Sexual dysfunction in advanced HIV disease. AIDS Care (1994) 0.82
Development of the Impact of Weight Loss Scale (IWLS): a psychometric study in a sample of men with HIV/AIDS. AIDS Care (1999) 0.82
Body-image dissatisfaction in gay versus heterosexual men: is there really a difference? J Clin Psychiatry (2004) 0.77
Body image and the complications of HIV treatment. Focus (2002) 0.77
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98
Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med (1984) 6.11
Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med (1977) 5.86
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol (1997) 5.76
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA (2001) 5.52
Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis (2001) 5.43
Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med (1989) 4.72
Transmission of the human immunodeficiency virus. N Engl J Med (1987) 4.17
Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome. N Engl J Med (1983) 3.67
Detection and treatment of hypertension at the work site. N Engl J Med (1975) 3.43
Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med (2000) 3.15
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol (1996) 2.86
Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns. Arch Intern Med (1985) 2.62
Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis (2001) 2.51
Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA (1989) 2.41
Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. N Engl J Med (1986) 2.40
Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med (1992) 2.36
The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications. Biochemistry (1966) 2.30
Disease progression and early viral dynamics in human immunodeficiency virus-infected children exposed to zidovudine during prenatal and perinatal periods. J Infect Dis (2000) 2.25
Survival differences in patients with AIDS. J Acquir Immune Defic Syndr (1991) 2.23
Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell (2001) 2.20
High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA (1992) 2.19
Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study. J Acquir Immune Defic Syndr (2001) 2.13
Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med (1979) 2.06
Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep (1998) 1.98
Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med (1993) 1.92
Multicenter evaluation of hepatitis C RNA levels among female injection drug users. J Infect Dis (2001) 1.77
Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS (1988) 1.75
Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis (1999) 1.69
Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS (2001) 1.68
Emergency physician workload: a time study. Ann Emerg Med (1993) 1.66
Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA (1989) 1.63
Factors associated with unrecognized HIV-1 infection in an inner-city emergency department. Ann Emerg Med (1996) 1.54
A prospective study of HIV disease progression in female and male drug users. AIDS (1999) 1.54
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis (1996) 1.51
Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study. Obstet Gynecol (2001) 1.51
Lack of association of induration size with HIV infection among drug users reacting to tuberculin. Am J Respir Crit Care Med (1996) 1.47
Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol (1987) 1.47
Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1992) 1.40
Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health (1995) 1.40
High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol (1991) 1.39
Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV RNA amplification and detection. New York City Perinatal HIV Transmission Collaborative Study. J Infect Dis (1997) 1.36
Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr (1990) 1.36
The underrecognition of HIV infection in women in an inner-city emergency room. Am J Public Health (1993) 1.35
Antibiotic activity in vitro against methicillin-resistant Staphylococcus epidermidis and therapy of an experimental infection. Antimicrob Agents Chemother (1979) 1.30
The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med (1985) 1.29
Adolescent heterosexual experience: a new typology. J Adolesc Health (1997) 1.28
Cancer incidence in women with or at risk for HIV. Int J Cancer (2001) 1.23
Oral findings in patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol (1987) 1.23
Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group. J Infect Dis (1998) 1.22
Infectious diarrhea in patients with AIDS. Dig Dis Sci (1988) 1.22
A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection. Infect Dis Obstet Gynecol (2001) 1.17
Comparison of the InPouch TV culture system and Diamond's modified medium for detection of Trichomonas vaginalis. J Clin Microbiol (1997) 1.16
A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis (1997) 1.11
Biological action of inosine analogs in Leishmania and Trypanosoma spp. Antimicrob Agents Chemother (1984) 1.11
High testicular salvage rate in torsion of the spermatic cord. J Urol (1982) 1.11
Prevalence and predictive value of overweight in an urban HIV care clinic. J Acquir Immune Defic Syndr (2001) 1.10
Community-acquired opportunistic infections and defective cellular immunity in heterosexual drug abusers and homosexual men. Am J Med (1983) 1.10
Implementation of tuberculosis infection control measures at HIV care and treatment sites in sub-Saharan Africa. Int J Tuberc Lung Dis (2012) 1.09
Reactions of cytosine derivatives with acidic buffer solutions. II. Studies on transamination, deamination, and deuterium exchange. Biochemistry (1967) 1.08
Lack of association of Streptococcus bovis with noncolonic gastrointestinal carcinoma. Am J Gastroenterol (1987) 1.06
Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection? J Infect Dis (1991) 1.06
Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med (2001) 1.06
Pneumocystis carinii pneumonia therapy with 9-deazainosine in rats. Diagn Microbiol Infect Dis (1987) 1.05
Nucleosides. 73. Ribosyl analogs of chloramphenicol. J Org Chem (1971) 1.05
Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer (1994) 1.03
An effective hospital-based pneumococcal immunization program. Arch Intern Med (1986) 1.02
A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY. Am J Public Health (1996) 1.02
Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. Am J Obstet Gynecol (2001) 1.01
Correlates of voluntary human immunodeficiency virus antibody testing reported by postpartum women. J Am Med Womens Assoc (1997) 1.01
A prospective study of tuberculosis and HIV disease progression. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.01
Mycobacterium gordonae in the acquired immunodeficiency syndrome. Ann Intern Med (1984) 1.00
Activity of inosine analogs against Pneumocystis carinii in culture. Antimicrob Agents Chemother (1986) 1.00
Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection. HIV Epidemiology Research Study (HERS) Group. Clin Infect Dis (1998) 1.00
Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS. J Leukoc Biol (2006) 0.99
Gender differences in HIV risk behaviors in an adult emergency department in New York City. J Urban Health (1999) 0.99
Oropharyngeal Candida colonization and human immunodeficiency virus type 1 infection. J Infect Dis (2000) 0.98
Abnormal glucose metabolism among older men with or at risk of HIV infection. HIV Med (2006) 0.97
The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2001) 0.97
Vitamin A deficiency and maternal-infant transmissions of HIV in two metropolitan areas in the United States. AIDS (1997) 0.96